Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie J Schrag

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Vaccine|September 28, 2017
Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United StatesSun-Young Kim, Chi Nguyen, Louise B Russell, et al.
Plos One|April 8, 2016
Invasive Group B Streptococcal Disease in South Africa: Importance of Surveillance MethodologyVanessa Quan, Jennifer R Verani, Cheryl Cohen, et al.
American Journal of Infection Control|December 22, 2009
Outbreak of late-onset group B Streptococcus in a neonatal intensive care unitJennifer K MacFarquhar, Timothy F Jones, Amy M Woron, et al.
Vaccine|February 18, 2014
Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South AfricaSun-Young Kim, Louise B Russell, Jeehyun Park, et al.
The Pediatric Infectious Disease Journal|May 9, 2012
Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South AfricaStephanie J Schrag, Clare L Cutland, Elizabeth R Zell, et al.
The Pediatric Infectious Disease Journal|May 24, 2016
Disease Burden of Group B Streptococcus Among Infants in Sub-Saharan Africa: A Systematic Literature Review and Meta-analysisAnushua Sinha, Louise B Russell, Sara Tomczyk, et al.
Vaccine|November 14, 2017
Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan AfricaLouise B Russell, Sun-Young Kim, Ben Cosgriff, et al.
Obstetrics and Gynecology|May 27, 2010
Adherence to perinatal group B streptococcal prevention guidelinesWilliam P Goins, Thomas R Talbot, William Schaffner, et al.
JAMA|January 21, 2022
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta VariantsEmma K Accorsi, Amadea Britton, Katherine E Fleming-Dutra, et al.
Pediatrics|August 8, 2012
Maternal HIV infection and vertical transmission of pathogenic bacteriaClare L Cutland, Stephanie J Schrag, Elizabeth R Zell, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Vaccine|September 28, 2017
Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United StatesSun-Young Kim, Chi Nguyen, Louise B Russell, et al.
Plos One|April 8, 2016
Invasive Group B Streptococcal Disease in South Africa: Importance of Surveillance MethodologyVanessa Quan, Jennifer R Verani, Cheryl Cohen, et al.
American Journal of Infection Control|December 22, 2009
Outbreak of late-onset group B Streptococcus in a neonatal intensive care unitJennifer K MacFarquhar, Timothy F Jones, Amy M Woron, et al.
Vaccine|February 18, 2014
Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South AfricaSun-Young Kim, Louise B Russell, Jeehyun Park, et al.
The Pediatric Infectious Disease Journal|May 9, 2012
Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South AfricaStephanie J Schrag, Clare L Cutland, Elizabeth R Zell, et al.
The Pediatric Infectious Disease Journal|May 24, 2016
Disease Burden of Group B Streptococcus Among Infants in Sub-Saharan Africa: A Systematic Literature Review and Meta-analysisAnushua Sinha, Louise B Russell, Sara Tomczyk, et al.
Vaccine|November 14, 2017
Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan AfricaLouise B Russell, Sun-Young Kim, Ben Cosgriff, et al.
Obstetrics and Gynecology|May 27, 2010
Adherence to perinatal group B streptococcal prevention guidelinesWilliam P Goins, Thomas R Talbot, William Schaffner, et al.
JAMA|January 21, 2022
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta VariantsEmma K Accorsi, Amadea Britton, Katherine E Fleming-Dutra, et al.
Pediatrics|August 8, 2012
Maternal HIV infection and vertical transmission of pathogenic bacteriaClare L Cutland, Stephanie J Schrag, Elizabeth R Zell, et al.
Pageof 13